As of 2024-12-12, the Intrinsic Value of New Nordic Healthbrands AB (NNH.ST) is
11.62 SEK. This NNH.ST valuation is based on the model Discounted Cash Flows (Growth Exit 5Y).
With the current market price of 15.00 SEK, the upside of New Nordic Healthbrands AB is
-22.50%.
The range of the Intrinsic Value is 5.50 - 29.03 SEK
11.62 SEK
Intrinsic Value
NNH.ST Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| DCF (Growth 5y) |
5.50 - 29.03 |
11.62 |
-22.5% |
| DCF (Growth 10y) |
2.15 - 15.00 |
5.53 |
-63.1% |
| DCF (EBITDA 5y) |
8.83 - 13.22 |
10.33 |
-31.1% |
| DCF (EBITDA 10y) |
15.26 - 22.79 |
17.99 |
19.9% |
| Fair Value |
-9.33 - -9.33 |
-9.33 |
-162.19% |
| P/E |
(31.45) - (47.91) |
(38.71) |
-358.1% |
| EV/EBITDA |
(12.44) - 0.05 |
(6.86) |
-145.8% |
| EPV |
530.26 - 689.98 |
610.12 |
3967.5% |
| DDM - Stable |
(23.68) - (98.04) |
(60.86) |
-505.7% |
| DDM - Multi |
17.99 - 57.94 |
27.46 |
83.1% |
NNH.ST Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
92.93 |
| Beta |
-0.39 |
| Outstanding shares (mil) |
6.20 |
| Enterprise Value (mil) |
125.18 |
| Market risk premium |
5.10% |
| Cost of Equity |
5.61% |
| Cost of Debt |
7.26% |
| WACC |
5.60% |